Group 1 - The core point of the article is that Lianying Laser (SH 688518) held its 10th meeting of the 5th board of directors on October 24, 2025, to discuss the proposal for the 2025 first extraordinary general meeting of shareholders [1] - For the year 2024, Lianying Laser's revenue composition is as follows: 71.53% from power batteries, 17.5% from consumer electronics, 6.17% from automotive and hardware, 2.42% from other businesses, and 2.22% from other industries [1] - As of the report date, Lianying Laser has a market capitalization of 8.8 billion yuan [1] Group 2 - The article mentions that Chinese innovative drugs have sold overseas licenses worth 80 billion USD this year, highlighting the booming secondary market in biomedicine [1] - A dialogue with Lu Gang, a partner at Chuangdong Investment, indicates that while the secondary market is thriving, the primary market is facing challenges in fundraising [1]
联赢激光:10月24日召开董事会会议